Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference

NEW YORK--()--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Morgan Stanley 2015 Global Health Care Conference on Thursday, September 17, 2015, in New York. Giovanni Caforio, M.D., chief executive officer, will answer questions about the company at 4:05 p.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Contacts

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Ranya Dajani, 609-252-5330
ranya.dajany@bms.com
Bill Szablewski, 609-252-5894
william.szablewski@bms.com

Release Summary

Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference

Contacts

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Ranya Dajani, 609-252-5330
ranya.dajany@bms.com
Bill Szablewski, 609-252-5894
william.szablewski@bms.com